Table S2 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

<p>Supplementary table 2</p>

Salvato in:

Dettagli Bibliografici
Autore principale:	Renee Maria Saliby (16426550) (author)
Altri autori:	Talal El Zarif (14959088) (author), Ziad Bakouny (15015803) (author), Valisha Shah (16426553) (author), Wanling Xie (15062851) (author), Ronan Flippot (16426556) (author), Thomas Denize (15028293) (author), M. Harry Kane (16426559) (author), Katrine N. Madsen (16426562) (author), Miriam Ficial (15015800) (author), Laure Hirsch (16426565) (author), Xiao X. Wei (15032322) (author), John A. Steinharter (16426568) (author), Lauren C. Harshman (16426571) (author), Ulka N. Vaishampayan (15051039) (author), Mariano Severgnini (16426574) (author), David F. McDermott (16426577) (author), Gwo-Shu Mary Lee (15045378) (author), Wenxin Xu (15015872) (author), Eliezer M. Van Allen (15054227) (author), Bradley A. McGregor (15037805) (author), Sabina Signoretti (14954811) (author), Toni K. Choueiri (15043079) (author), Rana R. McKay (15062884) (author), David A. Braun (15043076) (author)
Pubblicazione:	2025
Soggetti:	Cancer Tumor Biology Cancer Detection and Diagnosis Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Biomarkers Serum biomarkers Genitourinary Cancers Renal cancer Immunotherapy Checkpoint blockade Precision Medicine Translational Research Tumor Microenvironment Immune cells and the microenvironment
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi